-

CRNC Stock Investigation: Robbins LLP Investigates Cerence Inc. (CRNC) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Cerence Inc. (NASDAQ: CRNC) and its officers and directors to determine if they breached their fiduciary duties and violated securities laws. Cerence builds artificial intelligence-powered virtual assistants primarily for the automotive market.

If you would like more information about our investigation of Cerence Inc.'s misconduct, click here.

What Is This Case About: According to a class action complaint filed against Cerence, between February 8, 2021 and February 4, 2022, defendants failed to disclose that: (1) the global semiconductor shortage had a materially negative impact on demand for Cerence's software licenses; and (2) defendants masked the impact of the semiconductor shortage on demand for the Company's software licenses by pulling forward sales. As a result, defendants' statements about Cerence's business, operations, and prospects were false and misleading.

On February 7, 2022, Cerence announced its financial results for the fiscal first quarter of 2022, providing "a 9% decrease at the midpoint compared to the initial FY22 guidance provided on November 22, 2021, and a 3% decrease at the mid-point compared to last year's actual revenue of $387 million." Further, the Company announced it was "withdrawing the fiscal [20]24 target model previously provided…" In response, the price of Cerence stock dropped more than 30%, from a closing price of $63.58 on February 4, 2022, to a closing price of $43.61 per share on February 7, 2022.

Next Steps: If you acquired shares of Cerence Inc. (CRNC) between February 8, 2021 and February 4, 2022, you have legal options. Contact us for more information.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Cerence Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:CRNC

Release Summary
CRNC Stock Investigation: Robbins LLP Investigates Cerence Inc. (CRNC) on Behalf of Shareholders
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

UWMC Stockholders Have Rights – If You Lost Money Investing in UWM Holdings Corporation Contact Robbins LLP for Information About Recovering Your Losses

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired UWM Holdings Corporation (NYSE: UWMC) securities between March 9, 2026 and August 5, 2026 (the "Class Period"). UWM engages in the origination, sale, and servicing of residential mortgage loans in the United States.The complaint alleges that UWM over-hedged itself in anticipation of its acquisition of Two Har...

DLVT Investors Have Rights – If You Lost Money Investing in Datavault AI Inc. Contact Robbins LLP for Information About Recovering Your Losses  

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Datavault AI Inc. (NASDAQ: DVLT) securities between September 4, 2024 and October 30, 2025. Datavault AI is a data sciences technology company, owns and operates data management platforms with high computing capabilities in North America, Asia Pacific, Europe, and internationally. Datavault was previously k...

Stockholder Alert: Robbins LLP Informs Investors of the Fractyl Health, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ: GUTS) securities between January 13, 2025 and January 29, 2026 (the "Class Period"). Fractyl is a metabolic therapeutics company that develops therapies for the treatment of type 2 diabetes (“T2D”) and obesity.The complaint alleges that Fractyl Health misled investors regarding t...
Back to Newsroom